BD, Medtronic, ARGON MEDICAL are Dominating the Asia-Pacific Bone Marrow Biopsy Market in 2018

Asia-Pacific Bone Marrow Biopsy Market is expected to grow with the CAGR of 6.3% in the forecast period of 2020 to 2027. The years considered for study are as mentioned below.

Access Full Report @

Asia-Pacific bone marrow biopsy market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.   

The major players dealing in Asia-Pacific bone marrow biopsy market are introducing strong range of products provider along with launching new products and adopting strategic initiative such as acquisition, agreement, business expansion, award and recognition into the market. This helped companies to maximize the sales with enhanced product portfolio.

For instance:

  • In September, 2018, BD entered into the divestiture of its soft tissue core needle biopsy line and Aspira product line to Merit Medical. This divestiture established its direct sales force and distribution partners in the Asia-Pacific market and has enhanced the revenue generation of the company.

BD is the dominating player in Asia-Pacific bone marrow biopsy market. The other key players existing in the market includes Argon Medical, Johnson & Johnson Services, Inc., Cardinal Health, Shanghai Mekon Medical Devices Co., Ltd., Medtronic, Merit Medical Systems, Teleflex Incorporated, Cook Medical (A subsidiary of Cook Group), SOMATEX Medical Technologies GmbH, GPC Medical Ltd., ST. STONE MEDICAL DEVICES PVT. LTD., SURETECH MEDICAL INC., and Zhejiang Kindly Medical Devices Co., Ltd. among others.

Asia-Pacific Bone Marrow Biopsy MarketBD

BD is headquartered is in New Jersey, the U.S. The company focuses on instrument's used for diagnostic infectious disease. The offer a variety of products like direct testing products, environmental systems, prepared media products and others. The company has multiple business segments including Medical, Life Science and Interventional. In this Interventional is the market focussed segment. The company has wide product portfolio such as Anesthesia delivery, biosciences, bio surgery, cervical cancer screening, diabetes care, drug delivery systems, gastrointestinal care, hazardous drug safety, hernia repair and fixation home care, infection prevention, infusion therapy, interventional specialties and other variety of products in which Interventional Specialties is the market focused category.

The company has wide presence across U.S., Europe & Asia. The company also has various subsidiary companies such as Accuri Cytometers, Inc.(Delaware), Accuri Cytometers (Europe), Ltd. (U.K.), Atto Bioscience, Inc. (Delaware), B-D (Cambridge U.K.) Ltd. (U.K.) and others.


Medtronic headquartered in Dublin, Ireland was founded in 1949. The company is focused on contributing to human welfare by alleviating pain, restoring health, and extending life. The company has multiple business segments including Cardiac and Vascular Group, Restorative Therapies Group, Minimally, Invasive Therapies Group, Surgical Innovations, Cardiac Rhythm & Heart Failure, Coronary & Structural Heart, Brain Therapies, Diabetes Group, Spine, Respiratory, Gastrointestinal, & Renal, Aortic, Peripheral & Venous, Specialty Therapies, Pain Therapies. In this Minimally, Invasive Therapies Group is the market focussed segment. The company has wide product portfolio including Advanced Surgical Technology, Cardiac Rhythm, Cardiovascular, Diabetes, Digestive & Gastrointestinal, Ear, Nose & Throat, General Surgery, Neurological, Oral Maxillofacial & Dental, Patient Monitoring, Renal Care, Respiratory, Spinal & Orthopaedic, Surgical Navigation & Imaging, Urological & Urogynecological, in which Spinal & Orthopaedic is the market focused category.

  • In 2011, Medtronic’s launched MARROWMAX Bone marrow aspiration needle kit and expanded its leading bone grafting product portfolio.  This allowed them to serve more customers worldwide and more revenue collection from the segment.

The company has presence in North America, South America, Middle East and Africa, Europe, Asia Pacific. The company also has various subsidiary companies such as Titan Spine, Inc. (U.S.), Given Imaging (Israel), Medtronic Japan Co., Ltd. (Japan), Aptus Endosystems (U.S.)


ARGON MEDICAL was founded in 2010. The company focused on providing products such as fluid management systems, urology, vascular access, dialysis, drapes, bone marrow biopsy and others. The company is engaged in providing wide range of product categories such as access needles, bone needles, biopsy needles, custom trays & accessories, derapes & covers, fluid management, specialty needles, hydrophilic coating, guidewires & sheath introducers in which biopsy needles is the market focused product category.

  • In 2013, Argon medical devices and Roundtable healthcare partners acquired Angiotech pharmaceutical “interventional products business”. They market and manufacture reusable and disposable biopsy products for the diagnosis of various diseases. This acquisition enhanced the company product portfolio for the biopsy needle category and helped in serving more customers across the globe.

The company is present in North America, Europe, Asia, & Middle East & Africa.